5xz0

Publication Abstract from PubMed

Four mutations (N23A, Y90A, R110A and F177A) were introduced into S19, a vaccine candidate for staphylococcal enterotoxin B (SEB), resulting in a lower binding affinity towards the T-cell receptor beta chain (TCB) and reducing its superantigen activity. The structure of S19 was solved and was superposed on the native or complex structure of SEB. In the superposition model, mutations that were introduced seemed to reduce the number of hydrogen bonds at the SEB-TCB interface. S19 also displayed an unexpected structural change around the flexible-loop region owing to the Y90A mutation. This local structural change provided evidence that the mutated form of S19 could have a lower affinity for major histocompatibility complex (MHC) class II than wild-type SEB.

Structure of the staphylococcal enterotoxin B vaccine candidate S19 showing eliminated superantigen activity.,Jeong WH, Song DH, Hur GH, Jeong ST Acta Crystallogr F Struct Biol Commun. 2017 Nov 1;73(Pt 11):595-600. doi:, 10.1107/S2053230X17014844. Epub 2017 Oct 20. PMID:29095152^[1]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.